Liquidia Corporation Common Stock vs Banco Santander SA — how do they compare? Liquidia Corporation Common Stock trades at $34.27 (market cap $3.04B), while Banco Santander SA trades at $13.59 (market cap $196.43B). The key difference: Banco Santander SA is far larger — about 64.6× Liquidia Corporation Common Stock's market cap, and Banco Santander SA pays a 2.16% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Banco Santander SA for 55 Days on average.
| LQDA | SAN | |
|---|---|---|
Market Cap | $3.04B | $196.43B |
Volume | 21,111,778 | 9,190,091 |
Sector | Health | Financials |
52-Week High | $91.03 | $15.05 |
52-Week Low | $22.02 | $9.65 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $2.94B | $360.59B |
Dividend Yield | — | 2.16% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Banco Santander (SAN) trades at $13.55, up 0.52% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong profitability with 26.25% net income margin and 16.07% ROE, though recent earnings show volatility with one beat and two misses in the last four quarters. Recent developments include the completion of Webster Financial acquisition, expanding U.S. presence and diversification.
SAN presents a compelling value case with reasonable P/E of 13.68 and strong analyst support (64% buy ratings), but faces headwinds from declining cash flows and high debt levels. The stock offers income potential with upcoming $0.14 dividend, though investors should monitor the sustainability of recent profit margins amid operational cash flow challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →